Skip to main
IVVD
IVVD logo

Invivyd Inc (IVVD) Stock Forecast & Price Target

Invivyd Inc (IVVD) Analyst Ratings

Based on 5 analyst ratings
Strong Buy
Strong Buy 80%
Buy 20%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Invivyd Inc. is positioned favorably due to its innovative antibody candidates, specifically PEMGARDA, which continues to demonstrate stable neutralizing activity against the currently dominant SARS-CoV-2 variants, suggesting a strong potential for sustained utility in high-risk populations, including immunocompromised individuals. The company’s robust Phase 3 data support a positive long-term outlook, while the expected launch trajectory for PEMGARDA is anticipated to improve in 2025 as providers gain clarity on its protective benefits. Additionally, Invivyd's ongoing commitment to address the needs of immunocompromised patients through the acceleration of its next-generation monoclonal antibody, VYD2311, further enhances the company's potential for revenue growth in a dynamic viral landscape.

Bears say

Invivyd Inc. faces significant challenges following the FDA's rejection of its request to expand the Emergency Use Authorization for PEMGARDA, highlighting the difficulties the company encounters in securing approvals for COVID-19 therapeutics. The setback not only diminishes the potential revenue from a broader treatment application but also emphasizes the need for Invivyd to diversify its pipeline in order to sustain long-term growth in a transitioning market. Additionally, the rejected submission for pemivibart indicates that despite promising clinical data, regulatory hurdles remain substantial, potentially impacting the company's overall valuation and future development prospects.

Invivyd Inc (IVVD) has been analyzed by 5 analysts, with a consensus rating of Strong Buy. 80% of analysts recommend a Strong Buy, 20% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Invivyd Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Invivyd Inc (IVVD) Forecast

Analysts have given Invivyd Inc (IVVD) a Strong Buy based on their latest research and market trends.

According to 5 analysts, Invivyd Inc (IVVD) has a Strong Buy consensus rating as of Aug 3, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $7.11, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $7.11, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Invivyd Inc (IVVD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.